CGTX Competitors & Alternatives
Compare Cognition Therapeutics, Inc. Common Stock with similar stocks in the same industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CGTX
Main Stock$1.16
Tradestie Score
54
Market Cap
$133.22M
Analyst Upside
+203.0%
Top Competitors
170 stocks in BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AMGN
Amgen Inc
|
$344.00
|
$160.70B | 26.5 | 66 | Compare |
|
GILD
Gilead Sciences Inc
|
$143.25
|
$137.92B | 21.6 | 63 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$845.42
|
$46.96B | 35.7 | 58 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$108.78
|
$24.57B | - | 59 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$179.62
|
$22.61B | 16.0 | 58 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$136.69
|
$13.59B | 32.5 | 62 | Compare |
|
EXEL
Exelixis Inc
|
$41.74
|
$11.09B | 17.4 | 43 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$42.85
|
$10.74B | - | 59 | Compare |
|
QGEN
QIAGEN N.V.
|
$52.50
|
$10.04B | 27.5 | 62 | Compare |
|
TECH
Bio-Techne Corp.
|
$63.79
|
$9.33B | 130.8 | 57 | Compare |
More CGTX Analysis
Data updated: Feb 02, 2026 | Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) (SIC 2836)
170 stocks in this industry